Cathie Wood Buys Shares Of Recursion Pharmaceuticals, Reduces Exposure To DraftKings And Genius Sports

Benzinga2023-08-08

On Monday, August 7, 2023, Cathie Wood-led Ark Invest made significant trades, with the most notable being a substantial acquisition of shares in Pacific Biosciences of California. This move comes ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1173562997?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-08-08 19:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1173562997","market":"us","top_or_hot":-1,"title":"Cathie Wood Buys Shares Of Recursion Pharmaceuticals, Reduces Exposure To DraftKings And Genius Sports","media":"Benzinga","content":"<div>\n<p>On Monday, August 7, 2023, Cathie Wood-led Ark Invest made significant trades, with the most notable being a substantial acquisition of shares in Pacific Biosciences of California. This move comes ...</p>\n\n<a href=\"https://www.benzinga.com/markets/equities/23/08/33613338/cathie-wood-buys-shares-of-pacific-biosciences-reduces-exposure-to-draftkings-and-genius-sports\">Source Link</a>\n\n</div>\n","source":"lsy1606299360108","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Buys Shares Of Recursion Pharmaceuticals, Reduces Exposure To DraftKings And Genius Sports</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Buys Shares Of Recursion Pharmaceuticals, Reduces Exposure To DraftKings And Genius Sports\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-08-08 19:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/markets/equities/23/08/33613338/cathie-wood-buys-shares-of-pacific-biosciences-reduces-exposure-to-draftkings-and-genius-sports><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>On Monday, August 7, 2023, Cathie Wood-led Ark Invest made significant trades, with the most notable being a substantial acquisition of shares in Pacific Biosciences of California. This move comes ...</p>\n\n<a href=\"https://www.benzinga.com/markets/equities/23/08/33613338/cathie-wood-buys-shares-of-pacific-biosciences-reduces-exposure-to-draftkings-and-genius-sports\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"QSI","symbol_name":"Quantum-Si Inc.","start_time":0,"source_url":"https://www.benzinga.com/markets/equities/23/08/33613338/cathie-wood-buys-shares-of-pacific-biosciences-reduces-exposure-to-draftkings-and-genius-sports","article_id":"1173562997","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1173562997","pubTimestamp":1691494637,"sourceInfo":{"source_id":"lsy1606299360108","name":"Benzinga"},"weMediaInfo":null,"summary":"On Monday, August 7, 2023, Cathie Wood-led Ark Invest made significant trades, with the most notable being a substantial acquisition of shares in Pacific Biosciences of California. This move comes sho","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"QSI":"Quantum-Si Inc.","IONS":"Ionis Pharmaceuticals, Inc","RXRX":"Recursion Pharmaceuticals, Inc.","DKNG":"DraftKings Inc.","ACCD":"Accolade, Inc.","PACB":"Pacific Biosciences of Californi","TXG":"10x Genomics, Inc."},"translate_title":"凯西·伍德购买递归制药公司的股份，减少对DraftKings和Genius Sports的投资","themeId":"b450f1d4aa0246ad9fdbfc0fc150ccb7","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ACCD":1.1,"DKNG":1.1,"IONS":1.1,"PACB":1.1,"QSI":1.1,"RXRX":1.1,"TXG":1.1},"content_text":"On Monday, August 7, 2023, Cathie Wood-led Ark Invest made significant trades, with the most notable being a substantial acquisition of shares in Pacific Biosciences of California. This move comes shortly after PACB announced its impressive second-quarter financial results, showcasing a 34% increase in revenue compared to the prior year.The Pacific Biosciences TradePacific Biosciences of California reported revenue of $47.6 million for the second quarter of 2023, marking a 34% increase from the $35.5 million in the prior year period. The company recognized revenue on 47 sequencing systems, including 45 Revio systems and 2 Sequel IIe systems.Ark purchased 659,805 shares of Pacific Biosciences Of California through its ARK Innovation ETF and ARK Genomic Revolution ETF. The trade was valued at $7.9 million, based on Monday’s closing price of $11.94.Ark Invest also made significant moves in the sports betting sector. The fund sold shares in DraftKings Inc and Genius Sports Ltd through its ARK Next Generation Internet ETF. The Wood-led company also sold DraftKings shares through the Innovation Fund.Ark’s total DraftKing share sale was valued at nearly $3 million at the closing price of $31.63. The Genius Sports sale amounted to $96,295 — based on Monday’s closing price of $7.19.This decision comes after DraftKings reported its Q2 results, showcasing operational excellence and widening its competitive edge. Analysts have highlighted DraftKings’ impressive market share gains, increased paying users, and revenue growth. The company’s performance has been attributed to a combination of operational efficiency, favorable market conditions, and strategic initiatives.Other Key Trades:Ark Invest bought 212,211 shares of Recursion Pharmaceuticals.28,908 shares of Accolade Inc were added to Ark’s portfolio.The fund also purchased 48,086 shares of Quantum.Ark Invest sold 20,117 shares of Ionis Pharmaceuticals Inc and 8,721 shares of 10x Genomics Inc.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":4,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1173562997"}